Boehringer pharma head to step down
The drugmaker announced changes in its board of managing directors, beginning with Allan Hillgrove.
FDA widens drug recall probe beyond heart meds
The FDA is expanding its investigation related into impurities found in a class of blood pressure medications.
The FDA is expanding its investigation related into impurities found in a class of blood pressure medications.
Blockbuster-bound Lilly drug wins another FDA nod
Eli Lilly’s Taltz has been given the go-ahead for a new indication.
Oklahoma judge rules against J&J in landmark trial
A judge has ordered Johnson & Johnson to pay $572 million in damages for its role in the opioid epidemic.
FDA fast tracks AstraZeneca diabetes drug
Farxig, has been given fast track status as a method to prevent heart and kidney failure in patients with chronic kidney disease.